International Conferences

Recommended Conferences for Neurochemistry

Neurochemistry

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums.

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules (such as psychopharmaceuticals, neuropeptides, or gastrotransmitters) that influence the function of neurons. Neuro chemistry is the sum of all the chemical messaging that takes place in the brain, which allows it to carry out its daily functions, like generating movement, ability to think, speak and listen, and to regulate the body systems. Many neurological conditions, such as depression, movement disorders, and Parkinson disease, are associated with imbalances of certain neurotransmitters in the brain. Neuro chemistry related disorders can be treated, allowing more people to overcome much of their social difficulty.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker. 

IIn order to accelate the discovery in the field of Neuro chemistry the ISN Committee for Aid and Education in Neurochemistry (CAEN) offers a range of financial support to scientists from countries with limited financial support who are performing research in Neurochemistry. The paediatric motor disorders research program has established a database for patients with paediatric neurotransmitter deficiency disorders (PNDs) associated with dopamine deficiency to better understand the disease. Around 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health and disability worldwide.

List of Best International Conferences:

• 5^th Neurology Congress, March 14-16, 2016 London, UK
• 2^nd Brain Disorders Conference, October 27-29, 2016 Chicago, USA
• 2^nd Neurological Disorders and Stroke Conference, April 28-30, 2016 Dubai, UAE
• 6^th Neurological Conference, May 19-20, 2016 San Antonio, USA
• 2^nd Parkinson’s Disease and Movement Disorders Conference, November 28-30, 2016 Chicago, USA
• 4^th Vascular Dementia Conference, June 30-July 2, 2016 Valencia, Spain
• 5^th Alzheimer’s Disease and Dementia Conference, September 29-Oct 1, 2016 London, UK
• 2^nd Adolescent Medicine and Child Psychology Conference, August 29- 31, 2016 Atlanta, USA
• 2^nd Depression, Anxiety and Stress Management Meeting, November 3-4, 2016 Valencia, Spain
• 2^nd Sleep Disorders Conference, November 28- 30, 2016 Chicago, USA
• The 12th Meeting of The Asian-Pacific Society for Neurochemistry
•  5^th International Regional Stress and Behavior Neuroscience and Bio psychiatry Conference
• 22^nd Annual International Stress and Behaviour Neuroscience and Bio psychiatry Conference
•  6^th International Neuroscience and Biological Psychiatry Regional ISBS Conference "Stress and Behavior: Kobe-2015"
• 25^th  Meeting of the International Society for Neurochemistry (ISN 2015)

Related International Societies

• American Society for Neurochemistry
• European Society for Neurochemistry
• Asian Pacific Society for Neurochemistry
• Japanese Society for Neurochemistry
• Argentine Society for Neurochemistry
• Society for Neurosciences
• Asian Pacific Society Neuroscience
• International Behavioral Neuroscience Society

   Related Companies

• • AstraZeneca plc

  • West Pharma

  • Axiva Sichem Biotech

  • Eli Lilly & Co.

  • Astellas Pharma

  • Johnson & Johnson

  • Pfizer

  • GlaxoSmithKline, 

  • Novartis AG, 

  • Sanofi, 

  • Forest Laboratories

  • Chelsea therapeutics

  • Merck & Co., 

  • Abbott Laboratories, 

  • UCB, 

  • International Society for Neurochemistry

  • American Society for Neurochemistry

  • European Society for Neurochemistry

  • Asian Pacific Society for Neurochemistry

  • Japanese Society for Neurochemistry

  • Argentine Society for Neurochemistry

  • Society for Neurosciences

  • Asian Pacific Society Neuroscience

  • International Behavioral Neuroscience Society

The World Health Organization (WHO) shows that 6.8 million people die every year as a result of neurological disorders, in Europe the economic cost of neurological diseases was estimated at about 139 billion euros in 2004. Total European 2010 cost of brain disorders was €798 billion and will grow to $480 billion by 2030.

The European average cost per person with a disorder of the brain ranged between €285 for headache and €30 000 for neuromuscular disorders. Total annual cost per disorder (in billion € 2010) was as follows: addiction 65.7; anxiety disorders 74.4; brain tumor 5.2; child/adolescent disorders 21.3; dementia 105.2; eating disorders 0.8; epilepsy 13.8; headache 43.5; mental retardation 43.3; mood disorders 113.4; multiple sclerosis 14.6; neuromuscular disorders 7.7; Parkinson's disease 13.9; personality disorders 27.3; psychotic disorders 93.9; sleep disorders 35.4; somatoform disorder 21.2; stroke 64.1; and traumatic brain injury 33.0.

This page will be updated regularly.

This page was last updated on April 20, 2024